Clinical trial
Treatment of Nicotine Dependence and Acute Depression
NCT00186446 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186446 |
|---|---|
| Title | Treatment of Nicotine Dependence and Acute Depression |
| Official title | Treatment of Nicotine Dependence and Acute Depression |
| Lead sponsor | Stanford University, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder, Nicotine Dependence |
| Intervention type | Drug |
| Interventions | bupropion and smoking cessation behavioral intervention |
| Enrollment | 20 |
| Start date | Jun 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 4, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: